8-K
Current Report
Nautilus Biotechnology, Inc. Filed Acc 0001808805-22-000107
Results of operations · Bylaws or fiscal year change
- Item 2.02 Results of operations and financial condition
- Item 5.03 Amendments to articles or bylaws; change in fiscal year
From the SEC's structured data for this filing
Loading naut-20221027.htm…